Intra-Cellular Therapies Share Holder Equity 2013-2024 | ITCI
- Intra-Cellular Therapies share holder equity for 2023 was $0.591B, a 9.85% decline from 2022.
- Intra-Cellular Therapies share holder equity for 2022 was $0.656B, a 57% increase from 2021.
- Intra-Cellular Therapies share holder equity for 2021 was $0.418B, a 36.38% decline from 2020.